Rahul Sarugaser
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
10
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rahul Sarugaser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ONCY Oncolytics Biotech | Initiates: Outperform | $3 | $1.14 | +163.16% | 1 | Apr 4, 2024 | |
| QIPT Quipt Home Medical | Downgrades: Market Perform | $10 | $2.62 | +281.68% | 1 | Feb 16, 2024 | |
| DNA Ginkgo Bioworks Holdings | Downgrades: Market Perform | $100 | $7.63 | +1,210.62% | 4 | Nov 15, 2023 | |
| PROF Profound Medical | Downgrades: Outperform | n/a | $8.20 | - | 2 | Aug 4, 2023 | |
| VFF Village Farms International | Downgrades: Market Perform | $11 → $2.5 | $0.87 | +188.32% | 2 | Feb 27, 2023 |
Oncolytics Biotech
Apr 4, 2024
Initiates: Outperform
Price Target: $3
Current: $1.14
Upside: +163.16%
Quipt Home Medical
Feb 16, 2024
Downgrades: Market Perform
Price Target: $10
Current: $2.62
Upside: +281.68%
Ginkgo Bioworks Holdings
Nov 15, 2023
Downgrades: Market Perform
Price Target: $100
Current: $7.63
Upside: +1,210.62%
Profound Medical
Aug 4, 2023
Downgrades: Outperform
Price Target: n/a
Current: $8.20
Upside: -
Village Farms International
Feb 27, 2023
Downgrades: Market Perform
Price Target: $11 → $2.5
Current: $0.87
Upside: +188.32%